Abstract:Yang-Hua Xiao, 1, 2 Mei-Fang Liu, 1 Hongwen Wu, 1, 3 De-Rong Xu, 1 Rui Zhao 1 1 Department of Clinical Laboratory, Medical Center for Burn and Plastic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China; 2 School of Public Health, Nanchang University, Nanchang, People's Republic of China; 3 Department of Medical Instruments, The First Affiliated Hospital of Nanchang University, Nanchang, People's Republic of China Correspondence: De-Rong Xu; Rui Zhao, Email ; Purpose: Metagenomic next-generation sequencing (mNGS) is a powerful yet unbiased method to identify pathogens in suspected infections. However, little is known about its clinical effectiveness. The present study aimed to assess the efficacy of mNGS in routine clinical practice. Patients and Methods: In this single-center retrospective cohort study, 518 patients with suspected infectious diseases were assessed for inclusion. Among them, each patient had undergone mNGS testing; 407 patients had undergone both microbial culture and mNGS testing. The result of mNGS testing was compared to microbial culture performed concurrently. The diagnostic performance of mNGS was evaluated using the comprehensive clinical diagnosis as the reference standard. Results: There was a significant difference in the positive detection rates of pathogens between mNGS and culture (331/407, 81.3% vs 79/407, 19.4%, P < 0.001). The sensitivity of mNGS was much higher than the culture method (79.5% vs 21.3%, P < 0.001), especially in sample types of sputum and bronchoalveolar lavage fluid (BALF). Notably, the sensitivity of blood mNGS was relatively lower than other sample types (67.4% vs 88.9– 93.8%). Pathogen cfDNA load based on standardized stringently mapped read number at the species level of microorganisms (SDSMRN) was significantly lower in blood than in other sample types from the same patient ( P = 0.0003). Importantly, mNGS directly led to a change of treatment regimen in 142 (27.4%) cases, including antibiotic escalation (15.3%), antibiotic de-escalation (9.1%), and early definitive diagnosis to initiate appropriate treatment (3.1%). Conclusion: Our in-house mNGS platform significantly improved the sensitivity for the diagnosis of infectious diseases. mNGS has the potential to improve clinical outcomes by optimizing antimicrobial therapy. Keywords: mNGS, infections, diagnostic, outcome Infections are the major cause of human deaths worldwide and present a rising threat to public security. 1 Antimicrobial resistance is a major concern that is threatening our ability to treat bacterial infections. 2 Delayed administration of antibiotics significantly increases the in-hospital mortality rate. 3 The tragic outcome of infection highlights the importance of timely diagnosis and appropriate antibiotic treatment of advanced diseases. Conventional microbiologic culture and microscopy remain the gold standard for diagnostics. Full identification of fastidious microorganisms is usually reserved for cases where an isolate is in pure culture. 4,5 However, it is a laborious and time-consuming procedure requiring several days to accomplish. Additionally, the sensitivity of the culture method depends largely on the duration of the infection and whether the patient has previously received antibiotic treatment. 6 For these reasons, rapid and accurate identification of unknown pathogenic microorganisms is critical to guide clinical decision-making about diagnosis and treatment. Molecular methods, such as polymerase chain reaction (PCR), are an alternative method when culture-based microbial detection methods fail. 7,8 However, the preselected target pathogens greatly limit the application of multiplex PCR in identifying infections caused by mixed pathogens. 9 PCR-based analyses may fail to detect unexpected, rare, or novel pathogens unless multiplexed PCRs covering all pathogenic microorganisms are employed. The clinical symptoms and etiologies of multiple infections are complex and diverse, so it is difficult to diagnose using conventional microbial methods. 10,11 This may complicate further treatment (eg, delay antimicrobial treatment, lead to antibiotics overuse, prolong hospitalizations, and increase healthcare costs). Accurate and timely diagnosis is essential for aggressive antimicrobial adjustment. These barriers are not insurmountable obstacles to treating infectious diseases. Metagenomic next-generation sequencing (mNGS) is an untargeted molecular approach that can theoretically detect all potential pathogens in a single experiment. As a -Abstract Truncated-

Pathogen quantitative efficacy of different spike-in internal controls and clinical application in central nervous system infection with metagenomic sequencing

Application of Next Generation Sequencing Technology on Contamination Monitoring in Microbiology Laboratory

Optimization of cerebrospinal fluid microbial DNA metagenomic sequencing diagnostics

Clinical application and evaluation of metagenomic next-generation sequencing in pathogen detection for suspected central nervous system infections

Metagenomic next-generation sequencing of cell-free and whole-cell DNA in diagnosing central nervous system infections

Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid

Clinical application and evaluation of metagenomic next-generation sequencing in suspected adult central nervous system infection

Clinical Application and Drug-Use-guidance Value of Metagenomic Next-Generation Sequencing in Central Nervous System Infection.

Development and Optimization of Metagenomic Next-Generation Sequencing Methods for Cerebrospinal Fluid Diagnostics

Use of Metagenomic Next-Generation Sequencing to Identify Pathogens Involved in Central Nervous System Infections

Evaluation of metagenomic and pathogen-targeted next-generation sequencing for diagnosis of meningitis and encephalitis in adults: A multicenter prospective observational cohort study in China

A prospective study of nanopore-targeted sequencing in the diagnosis of central nervous system infections

Metagenomic Next-generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Central Nervous System Infections: A Multicentre Cohort Study

A novel synthetic nucleic acid mixture for quantification of microbes by mNGS

The Performance of Metagenomic Next-Generation Sequencing In Suspected Central Nervous System Infection

Diagnostic Performance Of Central Nervous System Infections In Patients With Neurosurgical Intensive Care Using Metagenomic Next-Generation Sequencing: A Prospective Observational Study

Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Central Nervous System Infections: Advances and Challenges

Understanding Etiology of Community-Acquired Central Nervous System Infections Using Metagenomic Next-Generation Sequencing

Metagenomic next-generation sequencing of cerebrospinal fluid reveals etiological and microbiological features in patients with various central nervous system infections

Toward Accurate Diagnosis and Surveillance of Bacterial Infections Using Enhanced Strain-Level Metagenomic Next-Generation Sequencing of Infected Body Fluids.

Clinical Efficacy and Diagnostic Value of Metagenomic Next-Generation Sequencing for Pathogen Detection in Patients with Suspected Infectious Diseases: A Retrospective Study from a Large Tertiary Hospital